Page last updated: 2024-09-02

oxymatrine and Cognition Disorders

oxymatrine has been researched along with Cognition Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jia, JP; Wang, SB	1

Other Studies

1 other study(ies) available for oxymatrine and Cognition Disorders

Article	Year
Oxymatrine attenuates diabetes-associated cognitive deficits in rats. Acta pharmacologica Sinica, 2014, Volume: 35, Issue:3 Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Antioxidants; Behavior, Animal; Blood Glucose; Body Weight; Caspase 3; Cerebral Cortex; Cognition; Cognition Disorders; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Glutathione; Hippocampus; Inflammation Mediators; Interleukin-1beta; Male; Malondialdehyde; Maze Learning; Memory; Motor Activity; Oxidative Stress; Quinolizines; Rats, Wistar; Streptozocin; Superoxide Dismutase; Time Factors; Transcription Factor RelA; Tumor Necrosis Factor-alpha	2014

Article

Year

Oxymatrine attenuates diabetes-associated cognitive deficits in rats.

Acta pharmacologica Sinica, 2014, Volume: 35, Issue:3

Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Antioxidants; Behavior, Animal; Blood Glucose; Body Weight; Caspase 3; Cerebral Cortex; Cognition; Cognition Disorders; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Glutathione; Hippocampus; Inflammation Mediators; Interleukin-1beta; Male; Malondialdehyde; Maze Learning; Memory; Motor Activity; Oxidative Stress; Quinolizines; Rats, Wistar; Streptozocin; Superoxide Dismutase; Time Factors; Transcription Factor RelA; Tumor Necrosis Factor-alpha

2014